Transgene Market Cap

Transgene has a market cap or net worth of €94.37 million as of February 21, 2025. Its market cap has decreased by -19.10% in one year.

Market Cap

94.37M

Enterprise Value

115.84M

Revenue

6.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.72

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 94.37M, a decrease of -37.86%. That is a compound annual growth rate of -1.75%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	94.37M	5.15%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	134.55B
Sanofi	129.97B
Sartorius Stedim Biotech	19.83B
bioMérieux	13.45B
Eurofins Scientific SE	9.28B
Ipsen	9.05B
Virbac	2.55B
emeis Société anonyme	1.40B

Market Cap Rankings